Oxomics is awarded £1.25m in Innovate UK Biomedical Catalyst funding


We are thrilled to announced that Oxomics has been awarded £1.25m in Innovate UK Biomedical Catalyst grant funding to accelerate the development of our AI and metabolite-based cancer detection technology.

Dr James Larkin, CEO and co-founder, said: “This is a fantastic achievement for all the team and will be absolutely transformative for our ability to drive our technology development. I’m looking forward to the day where our test is available for every doctor and patient who needs it.”

Oxomics technology diagnoses cancer using a simple, universal blood test, coupled with machine learning which identifies cancer-specific patterns of small molecules in the blood called metabolites. Our test will fit into existing patient care pathways and offers rapid earlier diagnoses, allowing referral of the right patients for the right imaging at the right time, improving patient outcomes.

We have already shown that our technology can be used to accurately find cancer in an under-served population of patients with nonspecific symptoms, including cases where we found cancers before they were visible by imaging.

The support from this Biomedical Catalyst award will allow us to drive our technology development further, by demonstrating that we can accurately find individual cancers in key patient populations. This critical step will move us towards the point where our tests are available for everyday use by doctors.

About the Biomedical Catalyst

The Biomedical Catalyst is Innovate UK’s flagship grant funding mechanism helping small and medium-sized businesses test and develop innovative health and care solutions across life sciences, including therapeutics, medical devices, and digital health. The Biomedical Catalyst transforms innovative ideas into commercially viable businesses. For more information visit

About Innovate UK

Innovate UK is the UK’s innovation agency. They help UK businesses to grow through innovation. The government’s vision is for the UK to be a global hub for innovation by 2035. Their mission in achieving that is to help companies to grow through their development and commercialisation of new products, processes and services, supported by an outstanding innovation ecosystem that is agile, inclusive and easy to navigate. For more information visit